← Eichor
Study identifier: NCT07662330 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Assessment of the Effects and Safety of Spermidine Supplementation on Blood Lipids and Body Weight in Overweight or Obese Individuals With Hyperlipidemia

Condition: Obesity & Overweight · Hyperlipidemia  ·  Sponsor: Shanghai 10th People's Hospital

PhaseNA
Planned participants50
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersNo

About this study

Evaluate the effect of spermidine supplementation on lipid profile changes in individuals with overweight or obesity accompanied by hyperlipidemia. Analyze the impact of spermidine on metabolic parameters and assess the safety of spermidine supplementation, including liver and kidney function, gastrointestinal reactions, and other adverse effects.

This description comes directly from the study's public registry record.

Talk to the study team

Bu Le  ·  +86 17701621016  ·  geyingjun@hotmail.com

Always discuss trial participation with your own doctor first.

Locations (1)

Shanghai Tenth People'S HospitalShanghai, Shanghai Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07662330